Home

Footer

DeepDyve Logo
FacebookTwitter

Features

  • Search and discover articles on DeepDyve, PubMed, and Google Scholar
  • Read the full-text of open access and premium content
  • Organize articles with folders and bookmarks
  • Collaborate on and share articles and folders

Info

  • Pricing
  • Enterprise Plans
  • Browse Journals & Topics
  • About DeepDyve

Help

  • Help
  • Publishers
  • Contact Us

Popular Topics

  • COVID-19
  • Climate Change
  • Biopharmaceuticals
Terms |
Privacy |
Security |
Help |
Enterprise Plans |
Contact Us

Select data courtesy of the U.S. National Library of Medicine.

© 2023 DeepDyve, Inc. All rights reserved.

Current Urology

Subject:
Oncology
Publisher:
S. Karger AG —
Karger
ISSN:
1661-7649
Scimago Journal Rank:
15

2023

Volume 17
Issue 3 (Sep)Issue 2 (Jun)Issue 1 (Mar)

2022

Volume 16
Issue 4 (Dec)Issue 3 (Sep)Issue 2 (Jun)Issue 1 (Mar)

2021

Volume 15
Issue 4 (Dec)Issue 3 (Sep)Issue 2 (Jun)

2020

Volume 14
Issue 4 (Jan)Issue 3 (Jan)Issue 2 (Jan)Issue 1 (Jan)
Volume 13
Issue 4 (Jan)

2019

Volume 13
Issue 3 (Jan)Issue 2 (Jan)Issue 1 (Jan)
Volume 12
Issue 4 (Jan)Issue 3 (Jan)Issue 2 (Jan)

2018

Volume 12
Issue 1 (Jan)
Volume 11
Issue 4 (Jan)Issue 3 (Jan)

2017

Volume 11
Issue 2 (Jan)Issue 1 (Jan)
Volume 10
Issue 4 (Jan)Issue 3 (Jan)Issue 2 (Jan)Issue 1 (Jan)
Volume 9
Issue 4 (Jan)

2016

Volume 9
Issue 4 (Jan)Issue 3 (Jan)Issue 2 (Jan)Issue 1 (Jan)

2015

Volume 8
Issue 4 (Jan)Issue 3 (Jan)Issue 2 (Jan)Issue 1 (Jan)

2014

Volume 7
Issue 4 (Jan)Issue 3 (Jan)

2013

Volume 7
Issue 2 (Jan)Issue 1 (Jan)
Volume 6
Issue 4 (Jan)Issue 3 (Jan)

2012

Volume 6
Issue 3 (Jan)Issue 2 (Jan)Issue 1 (Jan)
Volume 5
Issue 4 (Jan)

2011

Volume 5
Issue 4 (Jan)Issue 3 (Jan)Issue 2 (Jan)Issue 1 (Jan)

2010

Volume 4
Issue 4 (Jan)Issue 3 (Jan)Issue 2 (Jan)Issue 1 (Jan)

2009

Volume 4
Issue 1 (Jan)
Volume 3
Issue 4 (Jan)Issue 3 (Jan)Issue 2 (Jan)Issue 1 (Jan)
Volume 2
Issue 4 (Jan)Issue 3 (Jan)

2008

Volume 2
Issue 2 (Jan)Issue 1 (Jan)
Volume 1
Issue 4 (Jan)Issue 3 (Jan)Issue 2 (Jan)

2007

Volume 1
Issue 1 (Jan)
journal article
LitStream Collection
Is Health-Related Quality of Life after Radical Cystectomy Using Validated Questionnaires Really Better in Patients with Ileal Orthotopic Neobladder Compared to Ileal Conduit: A Meta-Analysis of Retrospective Comparative Studies

Cerruto, Maria A.; D'Elia, Carolina; Siracusano, Salvatore; Porcaro, Antonio B.; Cacciamani, Giovanni; De Marchi, Davide; Niero, Mauro; Lonardi, Cristina; Iafrate, Massimo; Bassi, Pierfrancesco; Belgrano, Emanuele; Imbimbo, Ciro; Racioppi, Marco; Talamini, Renato; Ciciliato, Stefano; Toffoli, Laura; Rizzo, Michele; Visalli, Francesco; Verze, Paolo; Artibani, Walter

2017 Current Urology

doi: 10.1159/000447153pmid: 28785189

Introduction: From the most recent systematic revision of the literature, an orthotopic neobladder would seem to show marginally better health related quality of life (HR-QoL) scores compared with an ileal conduit. The aim of this study was to review all relevant published studies about the comparison between ileal orthotopic neobladder (IONB) and ileal conduit using validated HR-QoL questionnaires. Materials and Methods: Studies were identified by searching multiple literature databases. Data were synthesized using meta-analytic methods conformed to the PRISMA statement. Results: The literature search identified 10 papers; pooled effect sizes of combined quality of life outcomes for ileal conduit versus IONB showed a significantly better HR-QoL in patients with IONB (Hedges' g = 0.278; p = 0.000);. The present study has an important limitation due to the type of the analyzed comparative studies, all retrospective and not randomized. Conclusion: This meta-analysis of not-randomized, retrospective comparative studies on the impact of ileal conduit versus IONB on HR-QoL showed a significant advantage of IONB subgroups.
journal article
LitStream Collection
A Review of Translocation T(6;11) Renal Cell Carcinoma Tumors in the Adult Patient

Cutruzzula, Paulette; Cahn, David; Kivlin, Dana; Tong, Carmen; Edwards, Daniel; Amster, Melanie

2017 Current Urology

doi: 10.1159/000447154pmid: 28785190

Historically, T(6;11) renal cell carcinoma (RCC) has been associated with the pediatric and adolescent populations and documentation of this tumor in adults has been rare. However, the frequency of translocation renal cell carcinoma (TRCC) may be widely underestimated in the adult population due to an inadequate immunohistochemical workup or misdiagnosis from similar gross and histological findings to other RCC. A subset of MiT family translocation carcinomas, t(6:11) (p21;q12) translocation tumors cause an alpha-TFEB gene fusion. Morphologically, this neoplasm tends to mimic the various types of RCC's, including clear cell, papillary, and even epitheloid angiomyolipomas. Adult cases of TRCC have shown to behave more aggressively than their indolent pediatric counterpart, but due to the limited number of reported cases the true nature of these tumors has yet to be determined. The aim of this review is to bring an awareness of translocation RCC to better understand its diagnoses, treatment and prognosis, and, in turn, to allow for new cases to further highlight the behavior of this rare variant.
journal article
LitStream Collection
Preoperative Plasma Levels of Total Testosterone Associated with High Grade Pathology-Detected Prostate Cancer: Preliminary Results of a Prospective Study in a Contemporary Cohort of Patients

Porcaro, Antonio B.; De Luyk, Nicolò; Corsi, Paolo; Sebben, Marco; Tafuri, Alessandro; Cacciamani, Giovanni; De Marchi, Davide; Tamanini, Irene; Inverardi, Davide; Brunelli, Matteo; Cerruto, Maria A.; Salvagno, Gian L.; Guidi, Gian C.; Artibani, Walter

2017 Current Urology

doi: 10.1159/000447155pmid: 28785191

Objectives: To investigate the associations, if any, between preoperative plasma levels of total testosterone (TT) and pathology Gleason score (pGS) in a contemporary cohort of prostate cancer (PCa) patients. Materials and Methods: Between November 2014 and June 2015, plasma levels of TT were measured in 142 patients who underwent radical prostatectomy. Exclusion criteria were as follows: 5α-reductase inhibitors, LH-releasing hormone analogues, or testosterone replacement treatment. The entire cohort, assessed by continuous and categorical variables, was classified into two groups according to the pGS that included low-intermediate (pGS 6-7) and high grade (pGS > 7) cases. TT was evaluated as a continuous variable. Results: The cohort included 128 cases. High grade PCa was detected in 28 (21.8%) patients. Median plasma levels of both TT and prostate specific antigen (PSA) were significantly higher in these cases. In the clinical multivariate model, independent and positive predictors of pGS > 7 were TT (p = 0.041; OR = 1.004), PSA (p = 0.006; OR = 1.191), and bGS > 6 (p = 0.004; OR = 5.0); that is, a single unit increase in TT plasma levels increases the odds of having high grade PCa by 4%. Conclusion: In a contemporary cohort of patients, preoperative plasma levels of TT directly and independently associated with high grade PCa. High baseline plasma levels of TT might have clinical applications for managing PCa. New and well designed prospective studies dealing with this subject are required.
journal article
LitStream Collection
Holmium Laser Enucleation of the Prostate versus Laparoscopic Transcapsular Prostatectomy: Perioperative Results and Three-Month Follow-Up

Baldini, Arnaud; Fassi-Fehri, Hakim; Duarte, Ricardo C.; Crouzet, Sebastien; Ecochard, René; Abid, Nadia; Martin, Xavier; Badet, Lionel; Colombel, Marc

2017 Current Urology

doi: 10.1159/000447156pmid: 28785192

Purpose: Symptomatic benign prostatic hypertrophy greater than 70 cc used to be treated by invasive procedures. Holmium laser enucleation of prostate (HoLEP) and laparoscopic transcapsular prostatectomy (LTP) are two techniques whose efficacy has been demonstrated compared to standard onesmore invasive standard procedures. The objective was to evaluate and compare perioperative results from these two techniques for the treatment of benign prostatic hypertrophy greater than 70 cc. Methods: This was a non-randomized retrospective study comparing the HoLEP technique with LTP. From January 2012 to January 2015, 39 patients had HoLEP and 28 had LTP. Perioperative outcomes, complications, and functional results at 3 months were compared. A chi-2 squared test and Student's t test were used for statistical analysis. Results: In multivariate analysis, there was a statistically significant difference in favor of HoLEP for the duration of catheterization (1.9 vs. 3.7 days; p = 0.004) and the average length of stay (2.8 vs. 4.0 days, p = 0.010). There was a trend towards a greater decrease in postoperative hemoglobin levels in LTP (138 vs. 218 g/l; p = 0.082), which was statistically significant in univariate analysis (p = 0.033). Other endpoints were not significant, particularly the enucleated prostate volume compared to the total prostate volume (61.8 vs. 68.4%; p = 0.319) and postoperative complications. Conclusion: There was no increased morbidity for LTP compared to the HoLEP technique. However, the HoLEP technique appeared to be a less invasive technique, reducing the duration of catheterization, blood loss, and the average length of stay while maintaining good efficacy for the enucleated prostate volume.
journal article
LitStream Collection
Antegrade Ureteral Stenting is a Good Alternative for the Retrograde Approach

van der Meer, Rutger W.; Weltings, Saskia; van Erkel, Arian R.; Roshani, Hossain; Elzevier, Henk W.; van Dijk, Lukas C.; van Overhagen, Hans

2017 Current Urology

doi: 10.1159/000447157pmid: 28785193

Background/Aims: Double J (JJ) stents for treating obstructive ureteral pathology are generally inserted through a retrograde route with cystoscopic guidance. Antegrade percutaneous insertion using fluoroscopy can be performed alternatively but is less known. Indications, success rate and complications of antegrade ureteral stenting were evaluated. Methods: Data of consecutive patients in which antegrade ureteral stenting was performed were retrospectively analysed using the radiology information system and patient records. Patient characteristics, details of the antegrade JJ stent insertion procedure and registered complications were collected. Furthermore, it was investigated if prior to the antegrade procedure a retrograde attempt for JJ stent insertion was performed. Results: Total 130 attempts for antegrade JJ stent insertion were performed in 100 patients. A percutaneous nephrostomy catheter had already been placed in the majority of kidneys (n = 109) for initial treatment of hydronephrosis. Most prevelant indication for a JJ stent was obstructive ureteral pathology due to malignancy (n = 63). A JJ stent was successfully inserted in 125 of 130 procedures. In 21 cases, previous retrograde ureteral stenting had failed but, subsequent antegrade ureteral stenting was successful. There were 8 procedure related complications; 6 infections, 1 false tract and 1 malposition. Conclusion: Antegrade percutaneous insertion of a JJ stent is a good alternative for retrograde insertion.
journal article
LitStream Collection
Inflatable Penile Prosthesis Insertion in Men with Severe Intracorporal Fibrosis

Garber, Bruce B.; Lim, Caitlin

2017 Current Urology

doi: 10.1159/000447158pmid: 28785194

Objectives: To retrospectively review a series of men who underwent attempted inflatable penile prosthesis (IPP) insertion into severely scarred corpora, and to analyze the surgical techniques and instruments that contributed to a successful outcome. Patients and Methods: All IPP procedures done by a high-volume prosthetic surgeon during a 5-year period were retrospectively reviewed. Fourteen patients with severe intracorporal fibrosis underwent 15 attempted IPP insertion procedures, and are the subject of this review. Results: A standardized surgical approach was employed for all patients. Thirteen of the 15 procedures were successful (i.e., an IPP was inserted, with satisfactory cylinder position). One procedure failed due to corporal obliteration. One patient underwent an initial failed attempt, but was successfully implanted 10 months later. Two of the 14 patients (14%) developed peri-prosthetic infection and were explanted. Conclusion: IPP insertion into scarred corpora is difficult and occasionally impossible. We have developed a standardized surgical approach for these cases, using limited corporal excavation, followed by the use of sequential Uramix and then Carrion-Rossello cavernotomes, that we feel has improved our chance of a successful implant. However, due to the rarity of these cases, it is not possible to make definitive statements concerning the optimal surgical technique.
journal article
LitStream Collection
The Modulating Effects of Benign Prostate Enlargement Medications on Upgrading Predictors in Patients with Gleason 6 at Biopsy

Jazayeri, Seyed Behzad; Kwon, Young S.; McBride, Russell; Leapman, Michael; Collingwood, Shemille; Hobbs, Adele; Samadi, David B.

2017 Current Urology

doi: 10.1159/000447159pmid: 28785195

Background: Upgrading following prostate biopsy is very common in clinical practice. This study investigated whether the use of 5-alpha reductase inhibitors (ARI) and alpha blockers affect known clinical predictors of Gleason score upgrading or not. Materials and Methods: A retrospective study on 998 patients treated with robotic assisted laparoscopic prostatectomy for clinically localized biopsy Gleason score 6 prostate cancer were studied. The logarithm of prostate specific antigen concentration, prostate size and tumor volume were compared on the basis of the medication history of 5-ARIs and alpha blockers in the cohort of biopsy Gleason 6 patients with benign prostatic hyperplasia history, and patients whose prostate sizes fall in the top quartile. We compared known clinical and pathologic characteristics associated with upgrading in regression models with and without the addition of medications. Results: Alpha blockers, but not 5-ARI were associated with a bigger prostate. Upgrading was associated with older age (OR 1.03, 95% CI 1.01-1.06), higher BMI (OR 1.00 CI 1.01-1.08), higher log prostate specific antigen (OR 7.32, CI 3.546-15.52), smaller prostate size (OR 0.97, CI 0.96-0.98), fewer biopsy cores (OR 0.96 CI 0.92-0.99), more positive cores (OR 1.20, CI 1.08-1.34), and higher percentage of tumor at biopsy (OR 1.02, CI 1.01-1.03). Neither of the two medication classes were a significant predictor of upgrading. Medications made minimal changes in the multivariate predictive models. Conclusion: Although, alpha blockers were associate with bigger prostate size, the modulating effects of alpha blockers and 5-ARIs on common predictors of Gleason score upgrading was not significant.
journal article
LitStream Collection
Emergent Embolization of a Very Late Detected Pseudoaneurysm at a Lower Pole Subsegmental Artery of the Kidney after Clampless Laparoscopic Partial Nephrectomy

Chiancone, Francesco; Fedelini, Maurizio; Pucci, Luigi; Di Lorenzo, Domenico; Meccariello, Clemente; Fedelini, Paolo

2017 Current Urology

doi: 10.1159/000447160pmid: 28785196

Renal artery pseudoaneurysm is a rare but life-threatening condition. Its incidence is higher after minimally invasive partial nephrectomy (PN) than after the open approach. We reported a case of a renal artery pseudoaneurysm occurred about four months after a clampless laparoscopic PN. A 49-year-old female underwent a clampless laparoscopic PN for a right renal tumor with high surgical complexity. The patient experienced an intraoperative blood loss from renal bed and the surgeons performed a deep medullary absorbable suture. Three months after surgery the patient underwent a renal ultrasonography with good results. The patient came to our emergency department 115 days after surgery with a hypovolemic shock stage 3. Her CT scan showed a pseudoaneurysm of a lower pole vessel of the right kidney. She underwent a superselective embolization of the segmental renal artery. The surgical complexity of the tumor, the anatomical relationships with the renal sinus and the deep medullary suture could be responsible for the development of the pseudoaneurysm. The authors presented an unusual case of a very late detected pseudoaneurysm of a renal vessel, suggesting that all very complex renal tumors removed with a minimally invasive technique should be followed up closely at least during the first six-months in order to early detect this major complication.
journal article
LitStream Collection
Neisseria Mucosa: A New Urinary Tract Pathogen?

Osses, Daniël F.; Dijkmans, Anneke C.; van Meurs, Alfred H.; Froeling, Frank M.

2017 Current Urology

doi: 10.1159/000447161pmid: 28785197

The most common complication of vesicoureteral reflux is urinary tract infection. We report a case of a urinary tract infection in a child with severe vesicoureteral reflux, caused by Neisseria mucosa, usually considered to be a commensal inhabitant of the oro- or nasopharynx.
journal article
LitStream Collection
Fracture Risk in Prostate Cancer during Hormonal Therapy

Kawahara, Takashi; Fusayasu, Shusei; Ohtake, Shinji; Ito, Hiroki; Miyoshi, Yasuhide; Yao, Masahiro; Uemura, Hiroji

2017 Current Urology

doi: 10.1159/000447162pmid: 28785198

Browse All Journals

Related Journals:

Lancet Oncology, TheCancer DiscoveryNature Reviews Clinical OncologySupportive Care in CancerEuropean Journal of Cancer CareCurrent Oncology ReportsJournal of OncologyCurrent OncologyTherapeutic Advances in Medical OncologyClinical Medicine Insights: Oncology